MeVis Medical Solutions AG develops, markets, and sells software for analyzing and evaluating image data to equipment manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological disorders. It offers X-ray modalities, including computed tomography, digital mammography, digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. The company also offers three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians, as well as internet-based special applications in teleradiology. In addition, its services are used for technical visualization and online training. The company was founded in 1992 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Deutschland AG.

MeVis Medical Solutions AG

NWI Group is a family-owned investment company based in Bremen that specializes in acquisitions and partnerships with companies generating between 20-100 million euros in revenue. The company has been active for over 25 years, focusing on long-term success rather than short-term investments. Self-described as market leaders in various sectors, they operate in twelve countries.

NWI Group

MeVis Medical Solutions AG develops software for image analysis and evaluation in medicine, focusing on the early detection and diagnostics of significant diseases such as cancer.

Metric
Company Name	MeVis Medical Solutions AG	NWI Group
Symbol	M3V
MSH ID	DE:MEVIS	DE:NWI-GROUP
Market	STOCKS	PRIVATE
Sector	Healthcare	Financial Services & Finance
Industry	Medical - Healthcare Information Services	Investment and Financial Services
Country	DE	DE
Stage
Employee Count	116
Website	mevis.de	nwi-group.de
LinkedIn
Founders

Metric
Market Cap	48.83M
Enterprise Value
Monthly Web Traffic		1.44K
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	18.32M
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income	5.20M
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.40
Operating Profit Margin	0.29
EBITDA Margin	0.30
Net Profit Margin	0.33
Return on Equity	0.51
Return on Assets	0.36
Return on Capital Employed	0.38

DE:MEVIS

MeVis Medical Solutions AG

Last Close

24.80

25/11 08:02

Market Cap

46.23M

Beta: -

Volume Today

207

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	2.64
EV Multiple	11.75

Metric
Days Sales Outstanding
Days Payables Outstanding	62.91
Days Inventory Outstanding	0.00
Operating Cycle	69.47
Cash Conversion Cycle	66.78
Asset Turnover	1.22

Metric
Operating Cash Flow	6.18M
Free Cash Flow	6.10M
Cash Flow to Debt	191.68K
Operating Cash Flow/Sales	0.01
Free Cash Flow Yield	0.13

Metric
Cash & Equivalents	8.18M
Accounts Receivable	1.67M
Inventory
Goodwill
Debt to Capitalization	0.00
Debt to Assets
Current Ratio	1.66
Quick Ratio	4.57

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue	0.03